← All trials
NCT04723069
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- Feb 28, 2022
- First posted
- Jan 25, 2021
- Last posted
- Oct 6, 2021
- Enrollment
- 198
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of KarachiLead sponsor
- University of KarachiReponsible party - principal investigator
- University of KarachiOverall official - principal investigator
- Zhuzhou Qianjin Pharmaceutical Co.Collaborator
- Jinnah Postgraduate Medical CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.